Guy Goodwin, FMedSci is currently WA Handley Professor of Psychiatry at the University of Oxford, Oxford, UK. He completed his medical degree and DPhil in physiology at the University of Oxford and, following his training in psychiatry, became a Clinical Scientist and Consultant Psychiatrist at the MRC Brain Metabolism Unit at the Royal Edinburgh Hospital, Edinburgh, UK.
Professor Goodwin’s research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments. He has been a lead investigator in clinical trials for bipolar affective disorder, including the BALANCE and CEQUEL studies. He works with industry in developing pre-clinical models of psychotropic drug action in man.
Professor Goodwin has served as a member of the Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, the Clinical Fellowships Panel and Advisory Board of the Medical Research Council, INSERM's ANR panel and currently Council of ECNP. He is a Fellow of the American College of Neuropsychopharmacology, was previously President of the British Association for Psychopharmacology (2004–2005), is current president of the European College of Neuropsychopharmacology and a NIHR Senior Investigator.